Selecting An R&D Data Management Platform To Support The Development Of Novel Antibody-Based Therapeutics

ProPharma assisted a commercial-stage biotech company near Munich in selecting an R&D data management platform focused on monoclonal antibody-based therapeutics. The company, previously reliant on paper-based processes, faced challenges as laboratory staff were occupied with day-to-day project work, leaving little time to seek a new electronic solution. The goal was to enhance efficiency and improve the health and safety of patients.

Upon receiving a recommendation from colleagues at a neighboring biotech, the company's representatives reached out to ProPharma for assistance. ProPharma conducted a thorough assessment of the company’s needs, identified the most suitable data management platforms, and guided the selection process. This collaboration ensured the implementation of a robust electronic system that streamlined R&D operations, increased data integrity, and ultimately supported the development of novel antibody-based therapeutics.